The Board granted an increased initial rating of 100 percent for chronic lymphocytic leukemia (CLL) and remanded the claim for service connection for basal cell carcinoma.
The deciding factor: The evidence was in approximate balance, so the benefit-of-the-doubt rule applied to grant the increased rating for CLL. A remand is required for a TERA examination regarding basal cell carcinoma due to potential herbicide exposure during active service.
- Claimed conditions
- Chronic Lymphocytic Leukemia (CLL), Basal Cell Carcinoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- March 21, 2025
- Citation
- A25026462
What this means for you
A partial grant means some issues were granted while others were denied or remanded — common in multi-issue claims. Look at which issues went which way, and how each was argued.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted an initial 100 percent rating for Chronic Lymphocytic Leukemia (CLL) from October 14, 2024.
- Granted
The Board granted the restoration of a 100 percent rating for Chronic Lymphocytic Leukemia (CLL) effective January 1, 2025, as the reduction in the disability rating was improper.
- Granted
The Board granted service connection for Chronic Lymphocytic Leukemia (CLL) based on the nexus between the Veteran's condition and in-service radiation exposure.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.